Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression

  1. Yiu Huen Tsang  Is a corresponding author
  2. Yumeng Wang
  3. Kathleen Kong
  4. Caitlin Grzeskowiak
  5. Oksana Zagorodna
  6. Turgut Dogruluk
  7. Hengyu Lu
  8. Nicole Villafane
  9. Venkata Hemanjani Bhavana
  10. Daniela Moreno
  11. Sarah H Elsea
  12. Han Liang
  13. Gordon B Mills
  14. Kenneth L Scott
  1. Baylor College of Medicine, United States
  2. The University of Texas MD Anderson Cancer Center, United States
  3. University of Texas MD Anderson Cancer Center, United States

Abstract

The melanoma-associated antigen family A (MAGEA) antigens are expressed in a wide variety of malignant tumors but not in adult somatic cells, rendering them attractive targets for cancer immunotherapy. Here we show that a number of cancer-associated MAGEA mutants that undergo proteasome-dependent degradation in vitro could negatively impact their utility as immunotherapeutic targets. Importantly, in pancreatic ductal adenocarcinoma cell models, MAGEA6 suppresses macroautophagy (autophagy). The inhibition of autophagy is released upon MAGEA6 degradation, which can be induced by nutrient deficiency or by acquisition of cancer-associated mutations. Using xenograft mouse models, we demonstrated that inhibition of autophagy is critical for tumor initiation whereas reinstitution of autophagy as a consequence of MAGEA6 degradation contributes to tumor progression. These findings could inform cancer immunotherapeutic strategies for targeting MAGEA antigens and provide mechanistic insight into the divergent roles of MAGEA6 during pancreatic cancer initiation and progression.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.Source data files have been provided for Figures 1.

The following previously published data sets were used

Article and author information

Author details

  1. Yiu Huen Tsang

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    For correspondence
    tsangsa@ohsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0895-6854
  2. Yumeng Wang

    Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kathleen Kong

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Caitlin Grzeskowiak

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Oksana Zagorodna

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Turgut Dogruluk

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9212-9471
  7. Hengyu Lu

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Nicole Villafane

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Venkata Hemanjani Bhavana

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Daniela Moreno

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Sarah H Elsea

    Molecular & Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Han Liang

    Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Gordon B Mills

    Department of System Biology, The University of Texas MD Anderson Cancer Center, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Kenneth L Scott

    Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institutes of Health (5R01CA211176-04)

  • Sarah H Elsea

National Institutes of Health (U24209851)

  • Gordon B Mills

Cullen Foundation

  • Turgut Dogruluk

Cancer Prevention and Research Institute of Texas (RP140102)

  • Hengyu Lu

National Institutes of Health (1F32CA221015-01)

  • Kathleen Kong

Cancer Prevention and Research Institute of Texas (RP120046)

  • Kenneth L Scott

American Association for Cancer Research (14-20-25-SCOT)

  • Kenneth L Scott

National Institutes of Health (U01CA168394)

  • Gordon B Mills

National Institutes of Health (1103109301)

  • Kenneth L Scott

Lustgarten Foundation (RFP-B-042)

  • Kenneth L Scott

National Institutes of Health (U01CA168394)

  • Kenneth L Scott

National Institutes of Health (R01CA175486)

  • Han Liang

National Institutes of Health (U24209851)

  • Han Liang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (AN-5428) of Baylor College of Medicine. The protocol was approved by the Committee on the Ethics of Animal Experiments of Baylor College of Medicine . All surgery was performed under isoflurane anesthesia, and every effort was made to minimize suffering.

Copyright

© 2020, Tsang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,934
    views
  • 265
    downloads
  • 18
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yiu Huen Tsang
  2. Yumeng Wang
  3. Kathleen Kong
  4. Caitlin Grzeskowiak
  5. Oksana Zagorodna
  6. Turgut Dogruluk
  7. Hengyu Lu
  8. Nicole Villafane
  9. Venkata Hemanjani Bhavana
  10. Daniela Moreno
  11. Sarah H Elsea
  12. Han Liang
  13. Gordon B Mills
  14. Kenneth L Scott
(2020)
Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression
eLife 9:e48963.
https://doi.org/10.7554/eLife.48963

Share this article

https://doi.org/10.7554/eLife.48963

Further reading

    1. Cancer Biology
    2. Computational and Systems Biology
    Rosalyn W Sayaman, Masaru Miyano ... Mark LaBarge
    Research Article

    Effects from aging in single cells are heterogenous, whereas at the organ- and tissue-levels aging phenotypes tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages: luminal epithelial and myoepithelial cells. Mammary luminal epithelia exhibit substantial stereotypical changes with age that merit attention because these cells are the putative cells-of-origin for breast cancers. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increase susceptibility to cancer initiation. We generated and analyzed transcriptomes from primary luminal epithelial and myoepithelial cells from younger <30 (y)ears old and older >55y women. In addition to age-dependent directional changes in gene expression, we observed increased transcriptional variance with age that contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and involved altered regulation of chromatin and genome organizers such as SATB1. Epithelial expression of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal that could be detected in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was highly predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue, and that their emergent phenotype both endows cells with the ability to become cancer-cells-of-origin and represents a biosensor that presages cancer susceptibility.

    1. Cancer Biology
    Jae Hun Shin, Jooyoung Park ... Alfred LM Bothwell
    Research Article

    Metastasis is the leading cause of cancer-related mortality. Paneth cells provide stem cell niche factors in homeostatic conditions, but the underlying mechanisms of cancer stem cell niche development are unclear. Here, we report that Dickkopf-2 (DKK2) is essential for the generation of cancer cells with Paneth cell properties during colon cancer metastasis. Splenic injection of Dkk2 knockout (KO) cancer organoids into C57BL/6 mice resulted in a significant reduction of liver metastases. Transcriptome analysis showed reduction of Paneth cell markers such as lysozymes in KO organoids. Single-cell RNA sequencing analyses of murine metastasized colon cancer cells and patient samples identified the presence of lysozyme positive cells with Paneth cell properties including enhanced glycolysis. Further analyses of transcriptome and chromatin accessibility suggested hepatocyte nuclear factor 4 alpha (HNF4A) as a downstream target of DKK2. Chromatin immunoprecipitation followed by sequencing analysis revealed that HNF4A binds to the promoter region of Sox9, a well-known transcription factor for Paneth cell differentiation. In the liver metastatic foci, DKK2 knockout rescued HNF4A protein levels followed by reduction of lysozyme positive cancer cells. Taken together, DKK2-mediated reduction of HNF4A protein promotes the generation of lysozyme positive cancer cells with Paneth cell properties in the metastasized colon cancers.